The Hilton London Olympia
October 22 - 24, 2018 - London UKHansonWadeLtd
info@hansonwade.com
Phone:+4402031418700
Precision CRISPR: Drug Development and Gene Therapy Congress returns for the 3rd time, just in time to face the building excitement in getting CRISPR gene therapy into the clinic. Take a look at the conference program and engage with this community today: https://bit.ly/2zdRx77Through a dynamic program of focused sessions, interactive discussions and networking opportunities, you will leave this meeting with a deep understanding of:- the challenges in delivery and reducing off-target effects in ex vivo and in vivo gene therapies- how the likes of GSK, Novartis, AstraZeneca and more, work towards improving the efficacy of functional screening and drug discovery- the most recent gene editing techniques and Cas variants poised to make precise gene editing all that more precisePreview Agenda Highlights: Discover how to detect in vitro and ex vivo cellular indel profiles and dynamics induced by different CRISPR/Cas9 delivery formats with insights from Eric Paul Bennett, University of Copenhagen Explore how Jacob Corn, ETH Zurich is forwarding gene repair in Human Hematopoietic Stem Cells and progressing towards translation of gene editing therapies for sickle cell disease Find out how Barry Rosen, VP, AstraZeneca is utilising precise genome engineering to empower drug discovery To find out more, get your event program here: https://bit.ly/2zdRx77